Jump vs a2z Radiology AI

Side-by-side comparison of AI visibility scores, market position, and capabilities

Jump

ChallengerFintech

AI Platform for Financial Advisors

Raised $80M Series B (Feb 2026) led by Insight Partners with Allianz Life and TIAA Ventures. 27,000 advisors on platform — 1 in 10 US advisors. Fastest-growing wealthtech application in history.

About

Jump is an AI operating platform for financial advisors, reaching 27,000 registered advisors — approximately 1 in 10 US financial advisors — with zero-to-scale adoption in under two years. The company raised $80 million in Series B financing in February 2026 led by Insight Partners, with Allianz Life Ventures and TIAA Ventures as strategic co-investors. The Series B was 4x the size of the Series A, reflecting exponential revenue acceleration.

Full profile

a2z Radiology AI

EmergingEnterprise AI

Medical Imaging AI

a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.

About

a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.

Full profile

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.